---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "BuTt2UmMgyOhDTL1HvqlxdTjkoliAE+sudVJG9UGFuMKIIZNUlLUsVXwxazBpWDdmGAp1tx6CRgt4+50MIs88XzdY1XuvDQ3IZ7OkbrUu9uBPmlesZGKOf/P7EgmwemqP98WfEXa9V+UJE6J21oqkCMlcM2vhaoT4OpTMDSL68mJ3sBkaUn2H5Uq2hhW55xOMY24ZHXznmsY0p66Jpm06AkWJckcYWthMQsC/tJTEbtCl3ZQjavArcNYdP1deGc9inStVoHMdONYGpE3zzEpQLHuc0FGZuzswFXJWqF8UzHp6K1mNQag3n8xBlnVEW2gscxB1a1BrQMMxMA1XInImfms75zokaNwF5vlfmbfzuo=;kyXyWcFNGYMcYVedTAUsVQ=="
---

